Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4856407
Max Phase: Preclinical
Molecular Formula: C22H18N4O2
Molecular Weight: 370.41
Molecule Type: Unknown
Associated Items:
ID: ALA4856407
Max Phase: Preclinical
Molecular Formula: C22H18N4O2
Molecular Weight: 370.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)c1c(C)nc2n(Cc3ccc4ccccc4n3)c3ccccc3n12
Standard InChI: InChI=1S/C22H18N4O2/c1-14-20(21(27)28-2)26-19-10-6-5-9-18(19)25(22(26)23-14)13-16-12-11-15-7-3-4-8-17(15)24-16/h3-12H,13H2,1-2H3
Standard InChI Key: VRCVKQPQMSBPBU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 370.41 | Molecular Weight (Monoisotopic): 370.1430 | AlogP: 3.98 | #Rotatable Bonds: 3 |
Polar Surface Area: 61.42 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.57 | CX LogP: 3.31 | CX LogD: 3.31 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.45 | Np Likeness Score: -1.15 |
1. Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z.. (2021) Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors., 225 [PMID:34416664] [10.1016/j.ejmech.2021.113750] |
Source(1):